MARKET

RAPT

RAPT

Rapt Therapeutics, Inc.
NASDAQ
0.7502
+0.0023
+0.31%
After Hours: 0.7700 +0.0198 +2.64% 19:54 05/14 EDT
OPEN
0.7500
PREV CLOSE
0.7479
HIGH
0.7915
LOW
0.7479
VOLUME
1.18M
TURNOVER
--
52 WEEK HIGH
4.830
52 WEEK LOW
0.7340
MARKET CAP
99.24M
P/E (TTM)
-0.3117
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RAPT last week (0505-0509)?
Weekly Report · 2d ago
RAPT Therapeutics: Promising Clinical Developments and Strong Financial Performance Justify Buy Rating
TipRanks · 2d ago
RAPT Therapeutics Reports Improved Q1 2025 Results
TipRanks · 5d ago
TimesSquare U.S. Small/Mid Cap Growth Q1 2025 Commentary
Seeking Alpha · 5d ago
RAPT Therapeutics GAAP EPS of -$0.08
Seeking Alpha · 6d ago
RAPT Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 6d ago
Rapt Therapeutics reports Q1 EPS (8c), consensus (14c)
TipRanks · 6d ago
*Rapt Therapeutics Had Cash and Cash Equivalents and Marketable Securities of $179.3M at March 31 >RAPT
Dow Jones · 6d ago
More
About RAPT
More
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapies for patients living with inflammatory and immunological diseases. Its lead drug candidate, RPT904, is a half-life extended monoclonal antibody (mAb) designed to bind free human immunoglobin E (IgE), which is being developing for the treatment of food allergy, chronic spontaneous urticaria (CSU) and potentially other inflammatory diseases. The Company’s oncology drug candidate, tivumecirnon, is an oral small-molecule C-C motif chemokine receptor 4 (CCR4) antagonist designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors.
Recently
Symbol
Price
%Change

Webull offers Rapt Therapeutics Inc stock information, including NASDAQ: RAPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RAPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RAPT stock methods without spending real money on the virtual paper trading platform.